GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
37 hedge funds and large institutions have $39.8M invested in Genocea Biosciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $57.4M → $39.8M (-$17.6M)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
37
Holding in Top 10
2
Calls
$4.8M
Puts
$1K
Top Buyers
| 1 | +$346K | |
| 2 | +$344K | |
| 3 | +$135K | |
| 4 |
Renaissance Technologies
New York
|
+$107K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$84.9K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$556K | |
| 3 | -$392K | |
| 4 |
VF
Virtu Financial
New York
|
-$363K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$295K |